Amy Kempf
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
- Animal Science and Zoology top 5%
- Animal Virus Infections Studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 24
- COVID-19 Clinical Research Studies 14
- SARS-CoV-2 detection and testing 6
-
- Glycosylation and Glycoproteins Research 4
- Co-authors
- Stefan Pöhlmann (29 shared papers)Markus Hoffmann (25 shared papers)Luise Graichen (18 shared papers)Hans‐Martin Jäck (17 shared papers)Sebastian Schulz (17 shared papers)Nadine Krüger (9 shared papers)Martin Sebastian Winkler (10 shared papers)Inga Nehlmeier (27 shared papers)
- Journals
- Cell Reports (4 papers)Cell (3 papers)Vaccines (3 papers)Viruses (3 papers)Cellular and Molecular Immunology (2 papers)
- Partner nations
- GermanyUnited KingdomFrance
In The Last Decade
Amy Kempf
26 papers receiving 1.7k citations
Amy Kempf's Hit Papers
Peers
Comparison fields: 5 of 82
- Infectious Diseases 1.4k
- Animal Science and Zoology 190
- Modeling and Simulation 74
- Health 66
- Neurology 102
Countries citing papers authored by Amy Kempf
This map shows the geographic impact of Amy Kempf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Kempf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Kempf more than expected).
Fields of papers citing papers by Amy Kempf
This network shows the impact of papers produced by Amy Kempf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Kempf. The network helps show where Amy Kempf may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Kempf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic Hit paper breakdown → | 2021 | 566 |
| 2 | SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies Hit paper breakdown → | 2021 | 566 |
| 3 | 2021 | 164 | |
| 4 | 2021 | 60 | |
| 5 | 2021 | 57 | |
| 6 | SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency Hit paper breakdown → | 2024 | 56 |
| 7 | 2023 | 41 | |
| 8 | 2022 | 30 | |
| 9 | 2021 | 29 | |
| 10 | 2023 | 24 | |
| 11 | 2022 | 24 | |
| 12 | 2022 | 20 | |
| 13 | 2023 | 10 | |
| 14 | 2024 | 7 | |
| 15 | 2022 | 5 | |
| 16 | 2024 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2022 | 4 | |
| 19 | 2025 | 3 | |
| 20 | 2024 | 3 |
About Amy Kempf
Amy Kempf is a scholar working on Infectious Diseases, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Animal Science and Zoology and Immunology, having authored 30 papers that have together received 1.7k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (24 papers), COVID-19 Clinical Research Studies (14 papers), SARS-CoV-2 detection and testing (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Animal Virus Infections Studies (5 papers), Glycosylation and Glycoproteins Research (4 papers), Long-Term Effects of COVID-19 (3 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Infectious Diseases (1.4k citations), Animal Science and Zoology (190 citations), Modeling and Simulation (74 citations), Health (66 citations) and Neurology (102 citations). Amy Kempf has collaborated with scholars based in Germany, United Kingdom and France. Frequent co-authors include Stefan Pöhlmann, Markus Hoffmann, Luise Graichen, Hans‐Martin Jäck, Sebastian Schulz, Nadine Krüger, Martin Sebastian Winkler, Inga Nehlmeier, Georg M. N. Behrens and Anna-Sophie Moldenhauer. Their work appears in journals such as Cell Reports, Cell, Vaccines, Viruses and Cellular and Molecular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.